2019 RA临床实践指南:血液透析中心血液传播病毒的管理

2019-06-01 英国肾脏病协会 英国肾脏病协会官网

2019年6月,英国肾脏病协会(RA)发布了血液透析中心血液传播病毒的管理指南。英国肾脏病协会(RA)肾病科血液传播病毒的管理指南于2008年发布,并不断进行修订和更新。新版的血液透析中心血液传播病毒的管理指南的主要目的是预防肾脏科血液传播病毒感染。

中文标题:

2019 RA临床实践指南:血液透析中心血液传播病毒的管理

英文标题:

Clinical Practice Guideline: Management of Blood Borne Viruses within the Haemodialysis Unit

发布机构:

英国肾脏病协会

发布日期:

2019-06-01

简要介绍:

2019年6月,英国肾脏病协会(RA)发布了血液透析中心血液传播病毒的管理指南。英国肾脏病协会(RA)肾病科血液传播病毒的管理指南于2008年发布,并不断进行修订和更新。新版的血液透析中心血液传播病毒的管理指南的主要目的是预防肾脏科血液传播病毒感染。 

拓展指南:血液透析相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 RA临床实践指南:血液透析中心血液传播病毒的管理)] GetToolGuiderByIdResponse(projectId=1, id=167261c001e55683, title=2019 RA临床实践指南:血液透析中心血液传播病毒的管理, enTitle=Clinical Practice Guideline: Management of Blood Borne Viruses within the Haemodialysis Unit, guiderFrom=英国肾脏病协会官网, authorId=null, author=, summary=2019年6月,英国肾脏病协会(RA)发布了血液透析中心血液传播病毒的管理指南。英国肾脏病协会(RA)肾病科血液传播病毒的管理指南于2008年发布,并不断进行修订和更新。新版的血液透析中心血液传播病毒的管理指南的主要目的是预防肾脏科血液传播病毒感染。 , cover=, journalId=null, articlesId=null, associationId=77, associationName=英国肾脏病协会, associationIntro=是面向英国肾脏病医生的专业机构。致力肾脏病知识的传播,以及肾脏病的预防和治疗,并为肾脏病患者提供减免服务。, copyright=0, guiderPublishedTime=Sat Jun 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年6月,英国肾脏病协会(RA)发布了血液透析中心血液传播病毒的管理指南。英国肾脏病协会(RA)肾病科血液传播病毒的管理指南于2008年发布,并不断进行修订和更新。新版的血液透析中心血液传播病毒的管理指南的主要目的是预防肾脏科血液传播病毒感染。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>血液透析</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=c8a681c001e51561" title="2019 ERBP临床实践指南:成人血液透析患者动静脉瘘和移植物围术期和术后护理" target=_blank>2019 ERBP临床实践指南:成人血液透析患者动静脉瘘和移植物围术期和术后护理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ac0e21c001ea6989" title="2019 AIOM/SIN共识意见:慢性肾病或血液透析的癌症患者的靶向治疗管理" target=_blank>2019 AIOM/SIN共识意见:慢性肾病或血液透析的癌症患者的靶向治疗管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d1afe1c001e2a452" title="2019 香港肾脏服务临床实践指南:血液透析" target=_blank>2019 香港肾脏服务临床实践指南:血液透析</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5616a1c001e18906" title="2019 ESPN共识:需要维持性血液透析儿童患者的血管通路" target=_blank>2019 ESPN共识:需要维持性血液透析儿童患者的血管通路</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=04afb1c00165522f" title="2018 KHA-CARI指南:血液透析中心感染控制建议" target=_blank>2018 KHA-CARI指南:血液透析中心感染控制建议</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E6%B6%B2%E9%80%8F%E6%9E%90" target=_blank>有关血液透析更多指南</a></ul>, tagList=[TagDto(tagId=64809, tagName=血液透析中心), TagDto(tagId=91651, tagName=血液传播病毒)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11415, appHits=273, showAppHits=8, pcHits=4747, showPcHits=7219, likes=85, shares=5, comments=3, approvalStatus=1, publishedTime=Sun Jun 30 23:46:39 CST 2019, publishedTimeString=2019-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 30 23:46:39 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:57:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 RA临床实践指南:血液透析中心血液传播病毒的管理)])
2019 RA临床实践指南:血液透析中心血液传播病毒的管理
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=973295, encodeId=c4359e32956b, content=这个网站是不是涵盖了所有的指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210613/aa85e7070db440a69286ab9ab29ac891/303c18d160b74fcdaa5d2c2791a47208.jpg, createdBy=26d75520215, createdName=ms9000001685664480, createdTime=Sun Jun 13 16:38:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368824, encodeId=23ad36882427, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRk75KAEKrLGic0S0IvH1aNynsEFQWiaNKdtzvtwj2kafCoPg2icYVbrfBCFiaS74X1uEiaaTTY1H9Xyem/0, createdBy=cec11614828, createdName=chunjianf, createdTime=Tue Jul 02 11:21:47 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368782, encodeId=5731368e8219, content=非常好的实践指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Mon Jul 01 20:37:01 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2021-06-13 ms9000001685664480

    这个网站是不是涵盖了所有的指南?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=973295, encodeId=c4359e32956b, content=这个网站是不是涵盖了所有的指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210613/aa85e7070db440a69286ab9ab29ac891/303c18d160b74fcdaa5d2c2791a47208.jpg, createdBy=26d75520215, createdName=ms9000001685664480, createdTime=Sun Jun 13 16:38:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368824, encodeId=23ad36882427, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRk75KAEKrLGic0S0IvH1aNynsEFQWiaNKdtzvtwj2kafCoPg2icYVbrfBCFiaS74X1uEiaaTTY1H9Xyem/0, createdBy=cec11614828, createdName=chunjianf, createdTime=Tue Jul 02 11:21:47 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368782, encodeId=5731368e8219, content=非常好的实践指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Mon Jul 01 20:37:01 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2019-07-02 chunjianf

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=973295, encodeId=c4359e32956b, content=这个网站是不是涵盖了所有的指南?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210613/aa85e7070db440a69286ab9ab29ac891/303c18d160b74fcdaa5d2c2791a47208.jpg, createdBy=26d75520215, createdName=ms9000001685664480, createdTime=Sun Jun 13 16:38:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368824, encodeId=23ad36882427, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRk75KAEKrLGic0S0IvH1aNynsEFQWiaNKdtzvtwj2kafCoPg2icYVbrfBCFiaS74X1uEiaaTTY1H9Xyem/0, createdBy=cec11614828, createdName=chunjianf, createdTime=Tue Jul 02 11:21:47 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368782, encodeId=5731368e8219, content=非常好的实践指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Mon Jul 01 20:37:01 CST 2019, time=2019-07-01, status=1, ipAttribution=)]
    2019-07-01 njwbhuang

    非常好的实践指南

    0